The injection of DOX/sh-1@PLT into mouse HCC models significantly increased the sensitivity of HCC cells to DOX treatment, probably through decreasing P-gp expression and intracellular ATP generation. This evidence concerns the gene PGP and hepatocellular carcinoma.